Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey

PURPOSE: The use of telemedicine expanded dramatically in March 2020 following the COVID-19 pandemic. We sought to assess oncologist perspectives on telemedicine’s present and future roles (both phone and video) for patients with cancer. METHODS: The National Comprehensive Cancer Network (NCCN) Electronic Health Record (EHR) Oncology Advisory Group formed a Workgroup to assess the state of…

Read the full article here

Source: JCO Oncology Practice

Categories: Hem/Onc News and Journals, Latest Headlines

Tags: covid19, JCOOP, telemedicine

Tweets with this article

ASCO Publications

A nat'l survey of >1000 providers finds that #telemedicine is considered safe & effective in certain clinical scenarios. Challenges include pt access to technology, clinical workflows, & uncertain insurance coverage post #COVID19 https://t.co/RIlZVT0AMd @AmyeTevaarwerkMD #JCOOP https://t.co/B2GP88LAZ5

JCO Oncology Advances

JCO Oncology Advances (JCO OA) is a fully open-access, online-only, and interdisciplinary journal committed to accelerating progress in the global fight against cancer. By providing…

ASCO Publications April 23, 2024

The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium

PURPOSE The International Prognostic Score (IPS) has been used in classic Hodgkin lymphoma (cHL) for 25 years. However, analyses have documented suboptimal performance of the…

ASCO Publications April 16, 2024

Knuckleheads: Understanding Patients Who Reject Treatment

Listen to ASCO’s Journal of Clinical Oncology essay, “Knuckleheads” by Dr. Timothy Gilligan, Vice Chair for Education at the Cleveland Clinic Taussig Cancer Institute. The…

ASCO Publications April 8, 2024

Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

PURPOSE To guide clinicians, adults with cancer, caregivers, researchers, and oncology institutions on the medical use of cannabis and cannabinoids, including synthetic cannabinoids and herbal…

ASCO Publications March 30, 2024

HER2 Gene Expression Levels Are Predictive and Prognostic in Patients With Metastatic Colorectal Cancer Enrolled in CALGB/SWOG 80405

PURPOSE The phase III Cancer and Leukemia Group B (CALGB)/SWOG 80405 trial found no difference in overall survival (OS) in patients with metastatic colorectal cancer…

ASCO Publications March 25, 2024

Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized Trial

PURPOSE To evaluate the effectiveness of endoscopic screening against incidence of and mortality from esophageal squamous cell carcinoma (ESCC). METHODS From January 2012 to September…

ASCO Publications March 25, 2024

Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort

PURPOSE Helicobacter pylori is the most common cause of infection-associated cancer worldwide. We aimed to evaluate the impact of H. pylori infection and treatment on…

ASCO Publications March 24, 2024

US Food and Drug Administration Approval Summary: Talazoparib in Combination With Enzalutamide for Treatment of Patients With Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

PURPOSE The US Food and Drug Administration (FDA) approved talazoparib with enzalutamide for first-line treatment of patients with homologous recombination repair (HRR) gene-mutated metastatic castration-resistant…

ASCO Publications March 23, 2024

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC)

PURPOSE A prospective phase II study examined the safety and efficacy of venetoclax combined with low-dose cytarabine (LDAC) in AML at first measurable residual disease…

ASCO Publications March 22, 2024

Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network

View all available purchase options and get full access to this article. Authors retain all rights in any data supplements associated with their articles. The…

ASCO Publications March 21, 2024

Related Articles